Biospecifics Technologies (BSTC) Reports Q2 EPS of $0.24

Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.24, versus $0.08 reported last year. Revenue for the quarter came in at $4.7 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
• Park National Corp. (PRK) Tops Q1 EPS by 36c